In Vivo Osteogenesis of Vancomycin Loaded Nanohydroxyapatite/Collagen/Calcium Sulfate Composite for Treating Infectious Bone Defect Induced by Chronic Osteomyelitis

Figure 3

Histological cross sections (4 μm) after infection with MRSA (40x): (a) cross section (HE) and (c) cross section (Masson) of nHAC/CSH group after 12 weeks of implantation; (b) cross section (HE) and (d) cross section (Masson) of VCM/nHAC/CSH group after 12 weeks of treatment and picrosirius red stained cross section after 12 weeks of implantation; (e) nHAC/CSH group; (f) VCM/nHAC/CSH group.

(a)

(b)

(c)

(d)

(e)

(f)